Cargando…

YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment

YIV-906 (PHY906) is a standardized botanical cancer drug candidate developed with a systems biology approach—inspired by a traditional Chinese herbal formulation, historically used to treat gastrointestinal symptoms including diarrhea, nausea and vomiting. In combination with chemotherapy and/or rad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiaochen, Lam, Wing, Jiang, Zaoli, Guan, Fulan, Han, Xue, Hu, Rong, Cai, Wei, Cheng, William, Liu, Shwu-Huey, Cheng, Peikwen, Cai, Yuping, Rattray, Nicholas J. W., Johnson, Caroline H., Chen, Lieping, Cheng, Yung-Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242098/ https://www.ncbi.nlm.nih.gov/pubmed/34188068 http://dx.doi.org/10.1038/s41598-021-91623-3

Ejemplares similares

Mechanism Based Quality Control (MBQC) of Herbal Products: A Case Study YIV-906 (PHY906)
por: Lam, Wing, et al.
Publicado: (2018)

YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity
por: Lam, Wing, et al.
Publicado: (2023)

YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy
por: Lam, Wing, et al.
Publicado: (2023)

The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018)
por: Lam, Wing, et al.
Publicado: (2014)

PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment
por: Lam, Wing, et al.
Publicado: (2015)

Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment
por: Wang, Ena, et al.
Publicado: (2011)

A comprehensive platform for quality control of botanical drugs (PhytomicsQC): a case study of Huangqin Tang (HQT) and PHY906
por: Tilton, Robert, et al.
Publicado: (2010)

A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma
por: Changou, Chun A., et al.
Publicado: (2020)

Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China
por: Wu, Jieya, et al.
Publicado: (2021)

Majority of Chinese Medicine Herb Category “Qing Re Yao” Have Multiple Mechanisms of Anti-inflammatory Activity
por: Guan, Fulan, et al.
Publicado: (2018)

Carpal Tunnel Syndrome: The Role of Occupational Factors Among 906 Workers
por: Ghasemi, Mohammad, et al.
Publicado: (2012)

Innate Immune Cells in the Esophageal Tumor Microenvironment
por: Cui, Kele, et al.
Publicado: (2021)

Fantasia in C minor, BWV906 Fifteen two-part inventions ; Fifteen three-part sinfonias (inventions) ; Chromatic fantasia and fugue : in D minor, BWV903 /
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1994)

Targeting tumour microenvironment by tyrosine kinase inhibitor
por: Tan, Hor-Yue, et al.
Publicado: (2018)

906 How Mandatory Public Reporting Undermines Infection Prevention: An Ethnographic Study
por: Szymczak, Julia E., et al.
Publicado: (2014)

SUN-906 To Function or Not to Function: A Rare Case of Metachronous Hormone Syndrome
por: Amine, Adele, et al.
Publicado: (2020)

Corrigendum: Innate Immune Cells in the Esophageal Tumor Microenvironment
por: Cui, Kele, et al.
Publicado: (2021)

Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906)
por: Scherzinger-Laude, Karine, et al.
Publicado: (2013)

MON-906 MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A: Familiar Case Report
por: Sousa, Barbara K P, et al.
Publicado: (2020)

Evaluation of the pharmacokinetics of trazpiroben (TAK‐906) in the presence and absence of the proton pump inhibitor esomeprazole
por: Kaur Mukker, Jatinder, et al.
Publicado: (2022)

Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)
por: Koblin, B, et al.
Publicado: (2012)

Operación y mantenimiento de la impresora MT 906 con proceso electrofotográfico láser /
por: Pérez Ramírez, Ángela
Publicado: (1994)

Development and Characterization of 1,906 EST-SSR Markers from Unigenes in Jute (Corchorus spp.)
por: Zhang, Liwu, et al.
Publicado: (2015)

The Significant Pathways and Genes Underlying the Colon Cancer Treatment by the Traditional Chinese Medicine PHY906
por: Su, Ziyuan, et al.
Publicado: (2017)

906. Surgical Site Infections in Children with Beta-Lactam Allergy: A Matched Cohort Study
por: Huang, Felicia Scaggs, et al.
Publicado: (2020)

Metabolic recovery of lipodystrophy, liver steatosis, and pancreatic β cell proliferation after the withdrawal of OSI-906
por: Tajima, Kazuki, et al.
Publicado: (2017)

In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction
por: Lu, Chih-Hao, et al.
Publicado: (2022)

Identification of AtHsp90.6 involved in early embryogenesis and its structure prediction by molecular dynamics simulations
por: Luo, An, et al.
Publicado: (2019)

WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11
por: Xing, Shuqin, et al.
Publicado: (2020)

906. Impact of Accelerate Rapid Diagnostic Technology on Time to Optimal Antimicrobial Therapy in Gram Negative Bloodstream Infection
por: Jung, Hye Lim, et al.
Publicado: (2022)

P906: GENOMIC ANALYSIS TO IDENTIFY DETERMINANTS OF INHERENT RESPONSE AND RESISTANCE TO ELRANATAMAB IN MAGNETISMM-3 COHORT A
por: Rodríguez-Otero, Paula, et al.
Publicado: (2023)

CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma
por: Guo, Xiao-Jun, et al.
Publicado: (2021)

Study of Malformin C, a Fungal Source Cyclic Pentapeptide, as an Anti-Cancer Drug
por: Wang, Jing, et al.
Publicado: (2015)

单中心906例真性红细胞增多症患者生存预后因素分析
Publicado: (2021)

906. Characteristics of Chronic Hepatitis B Patients with Severe Outcomes in a Large Integrated Healthcare System - 2008-2019
por: Florea, Ana, et al.
Publicado: (2021)

906. Risk of Shingles among Patients Aged 45–49 versus 50–54 Years in the US, by Immune Status
por: Miles, Amanda C, et al.
Publicado: (2023)

The Cutaneous Wound Innate Immunological Microenvironment
por: Kirchner, Stephen, et al.
Publicado: (2020)

Target tumor microenvironment by innate T cells
por: Li, Yan-Ruide, et al.
Publicado: (2022)

Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis
por: Ren, Ao, et al.
Publicado: (2023)

Synthesis of a Highly Stable Pd@CeO(2) Catalyst for Methane Combustion with the Synergistic Effect of Urea and Citric Acid
por: Cai, Guohui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j3oeh7sjbmt38kunukq75qmh4e